Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases

Published:2020-12-13 Issue:1 Volume:32 Page:29-41
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Harbi Maan H.¹,Smith Christopher W.¹,Nicolson Phillip L. R.¹²^ORCID,Watson Steve P.¹,Thomas Mark R.¹²³

Affiliation:

1. Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

2. University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

3. Sandwell and West Birmingham NHS Trust, Birmingham, UK

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2020.1849600

Reference163 articles.

1. Platelet Activation: The Mechanisms and Potential Biomarkers

2. Antiplatelet therapy in acute coronary syndromes

3. Izquierdo I, Barrachina MN, Hermida-Nogueira L, Casas V, Morán LA, Lacerenza S, Pinto-Llorente R, Eble JA, De Los Ríos V, Domínguez E, et al. A comprehensive tyrosine phosphoproteomic analysis reveals novel components of the platelet CLEC-2 signaling cascade. 2020.

4. Phosphoproteomic quantitation and causal analysis reveal pathways in GPVI/ITAM-mediated platelet activation programs

5. New advances in treating thrombotic diseases: GPVI as a platelet drug target

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?;Thrombosis Research;2024-09

2. Platelet FcγRIIA: An emerging regulator and biomarker in cardiovascular disease and cancer;Thrombosis Research;2024-06

3. Secondary Sites of the C‐type Lectin‐Like Fold;Chemistry – A European Journal;2024-04-30

4. C-type lectin-like receptor 2: roles and drug target;Thrombosis Journal;2024-03-19

5. Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction;Frontiers in Molecular Biosciences;2024-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3